Evidence map›Paper›PMID 38370663›Full record

ArticlebioRxiv : the preprint server for biology2025

Stress relaxing granular bioprinting materials enable complex and uniform organoid self-organization.

Austin J Graham, Michelle W L Khoo, Vasudha Srivastava, Sara Viragova, Honesty Kim, Kavita Parekh, Kelsey M Hennick, Malia Bird, Nadine Goldhammer, Jie Zeng Yu and 14 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Austin J GrahamDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA.ORCID 0000-0001-8924-181X
Michelle W L KhooChan Zuckerberg Biohub SF, San Francisco, CA.ORCID 0009-0005-0634-6904
Vasudha SrivastavaDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA.ORCID 0000-0001-8845-9518
Sara ViragovaDepartment of Orofacial Sciences, University of California San Francisco, San Francisco, CA.ORCID 0000-0003-0598-1445
Honesty KimDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA.
Kavita ParekhDepartment of Bioengineering, University of California Berkeley, Berkeley, CA.
Kelsey M HennickWeill Institute for Neurosciences, University of California San Francisco, San Francisco, CA.ORCID 0000-0002-6127-2400
Malia BirdDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA.ORCID 0000-0001-8871-155X
Nadine GoldhammerDepartment of Medicine, University of California San Francisco, San Francisco, CA.ORCID 0000-0003-1644-3984
Jie Zeng YuDepartment of Medicine, University of California San Francisco, San Francisco, CA.
Grace HuGraduate Program in Bioengineering, University of California San Francisco, San Francisco, CA and University of California Berkeley, Berkeley, CA.
Natasha T BrinkleyGraduate Program in Bioengineering, University of California San Francisco, San Francisco, CA and University of California Berkeley, Berkeley, CA.ORCID 0009-0006-1647-7489
Lucas PardoGraduate Program in Bioengineering, University of California San Francisco, San Francisco, CA and University of California Berkeley, Berkeley, CA.ORCID 0000-0003-3750-6788
Jasmine S AmayaDepartment of Bioengineering, University of California Berkeley, Berkeley, CA.
Cameron D MorleyDepartment of Bioengineering, University of California Berkeley, Berkeley, CA.ORCID 0000-0003-4333-3668
Nishant ChadhaWeill Institute for Neurosciences, University of California San Francisco, San Francisco, CA.
Paul LebelChan Zuckerberg Biohub SF, San Francisco, CA.ORCID 0000-0003-4569-1493
Sanjay KumarDepartment of Bioengineering, University of California Berkeley, Berkeley, CA.
Jennifer M RosenbluthChan Zuckerberg Biohub SF, San Francisco, CA.ORCID 0000-0003-1314-6976
Tomasz J NowakowskiWeill Institute for Neurosciences, University of California San Francisco, San Francisco, CA.ORCID 0000-0003-2345-4964
Ovijit ChaudhuriDepartment of Mechanical Engineering, Stanford University, Stanford, CA.ORCID 0000-0002-9287-3401
Ophir KleinDepartment of Orofacial Sciences, University of California San Francisco, San Francisco, CA.ORCID 0000-0002-6254-7082
Rafael Gómez-SjöbergChan Zuckerberg Biohub SF, San Francisco, CA.
Zev J GartnerDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA.ORCID 0000-0001-7803-1219

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Alan Ashworth · 1999 to 2026
$209.7M
Tissue mechanics reprograms the tissue to malignancy and metastasisR35CA242447 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VALERIE MARIE WEAVER · 2020 to 2026
$6.6M
The physical and molecular mechanisms of intestinal villus morphogenesis and repairR01DK126376 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Zev Jordan Gartner · 2020 to 2026
$4.2M
Understanding breast cancer progression as a defect in the mechanics of tissue self-organizationU01CA244109 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GARTNER, ZEV JORDAN, GOGA, ANDREI · 2020 to 2024
$3.0M
Developmental Timing During Cortical DevelopmentR01NS123263 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Tomasz Nowakowski · 2022 to 2026
$2.1M
Harnessing Electroactive Bacteria for Microbial Redox CatalysisR35GM133640 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI KEITZ, BENJAMIN KEITH · 2019 to 2023
$1.9M
Dynamically reconfigurable materials for 4D bioprinting of a human gut-brain axisK99EB037059 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Austin Joseph Graham · 2025 to 2026
$249k
NCI NIH HHS P30 CA082103NCI NIH HHS R35 CA242447NCI NIH HHS U01 CA244109NIBIB NIH HHS K99 EB037059NIDDK NIH HHS R01 DK126376NIGMS NIH HHS R35 GM133640NINDS NIH HHS R01 NS123263
6 · The paper itself

Abstract

Complex and robust self-organization requires defined initial conditions and dynamic boundaries - neighboring tissues and extracellular matrix (ECM) that actively evolve to guide morphogenesis. A major challenge in tissue engineering is identifying material properties that mimic dynamic tissue boundaries but that are compatible with the engineering tools necessary for controlling the initial conditions of culture. Here we describe a highly tunable granular biomaterial, MAGIC matrix, that supports long-term bioprinting and gold-standard tissue self-organization. MAGIC matrix is designed for two temperature regimes: at 4 °C it exhibits reversible yield-stress behavior to support hours-long high-fidelity 3D printing without compromising cell viability; when transferred to cell culture at 37 °C, the material cross-links and exhibits viscoelasticity and stress relaxation that can be tuned to match numerous conditions, including that of reconstituted basement membrane matrices like Matrigel. We demonstrate that the timescale of stress relaxation and loss tangent are decoupled in MAGIC matrices, allowing us to test the role of stress relaxation rate and strain-dependence across formulations with identical storage and loss moduli. We find that fast absolute stress relaxation rates and large relative deformation magnitudes are required to optimize for morphogenesis. We apply optimized MAGIC matrices toward precise extrusion bioprinting of saturated cell suspensions directly into 3D culture. The ability to carefully control initial conditions for tissue growth yields dramatic increases in organoid reproducibility and complexity across multiple tissue types. We also fabricate perfusable 3D microphysiological systems that experience large strains in response to pressurization due to the compliant and dynamic tissue boundaries. Combined, our results both identify key parameters for optimal organoid morphogenesis in an engineered material and lay the foundation for fabricating more complex and reproducible tissue morphologies by canalizing their self-organization in both space and time.

Identifiers

PMID38370663
PMCPMC10871257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.